DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 200 filers reported holding DENALI THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $475 | +28.0% | 16,097 | 0.0% | 0.02% | +16.7% |
| Q1 2023 | $371 | -54.6% | 16,097 | -45.3% | 0.02% | -60.0% |
| Q4 2022 | $818 | -99.7% | 29,426 | +285.5% | 0.04% | +221.4% |
| Q3 2022 | $234,000 | -52.1% | 7,634 | -49.8% | 0.01% | -56.2% |
| Q1 2022 | $489,000 | +48.6% | 15,203 | +106.3% | 0.03% | -22.0% |
| Q4 2021 | $329,000 | -11.6% | 7,369 | 0.0% | 0.04% | -18.0% |
| Q3 2021 | $372,000 | -31.1% | 7,369 | -76.2% | 0.05% | -68.9% |
| Q4 2019 | $540,000 | – | 30,974 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $298,165,000 | 48.02% |
| Bratton Capital Management, L.P. | 953,035 | $14,600,000 | 28.53% |
| Flagship Pioneering Inc. | 8,005,747 | $122,648,000 | 6.71% |
| Casdin Capital, LLC | 650,000 | $9,958,000,000 | 1.03% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $67,568,000 | 0.50% |
| MARK ASSET MANAGEMENT LP | 68,864 | $1,055,000 | 0.26% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 22,507 | $345,000 | 0.26% |
| Artal Group S.A. | 400,000 | $6,128,000 | 0.25% |
| PIER 88 INVESTMENT PARTNERS LLC | 40,610 | $622,000 | 0.24% |
| HAMILTON LANE ADVISORS LLC | 30,948 | $474,000 | 0.20% |